ATE212344T1 - Sulfonamide die einen sauerstoff-haltigen heterozyklus enthalten als inhibitoren von aspartyl-protease - Google Patents
Sulfonamide die einen sauerstoff-haltigen heterozyklus enthalten als inhibitoren von aspartyl-proteaseInfo
- Publication number
- ATE212344T1 ATE212344T1 AT96913811T AT96913811T ATE212344T1 AT E212344 T1 ATE212344 T1 AT E212344T1 AT 96913811 T AT96913811 T AT 96913811T AT 96913811 T AT96913811 T AT 96913811T AT E212344 T1 ATE212344 T1 AT E212344T1
- Authority
- AT
- Austria
- Prior art keywords
- sulfonamides
- inhibitors
- oxygen
- contain
- containing heterocycle
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D317/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D317/34—Oxygen atoms
- C07D317/36—Alkylene carbonates; Substituted alkylene carbonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/424,810 US5691372A (en) | 1995-04-19 | 1995-04-19 | Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease |
PCT/US1996/005473 WO1996033187A1 (en) | 1995-04-19 | 1996-04-18 | Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE212344T1 true ATE212344T1 (de) | 2002-02-15 |
Family
ID=23683966
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96913811T ATE212344T1 (de) | 1995-04-19 | 1996-04-18 | Sulfonamide die einen sauerstoff-haltigen heterozyklus enthalten als inhibitoren von aspartyl-protease |
AT05028389T ATE479674T1 (de) | 1995-04-19 | 1996-04-18 | Sulfonamide, die einen sauerstoffhaltigen heterozyklus enthalten als inhibitoren von aspartyl-protease |
AT01113575T ATE314360T1 (de) | 1995-04-19 | 1996-04-18 | Sulfonamide, die einen sauerstoffhaltigen heterozyklus enthalten als inhibitoren von aspartyl-protease |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05028389T ATE479674T1 (de) | 1995-04-19 | 1996-04-18 | Sulfonamide, die einen sauerstoffhaltigen heterozyklus enthalten als inhibitoren von aspartyl-protease |
AT01113575T ATE314360T1 (de) | 1995-04-19 | 1996-04-18 | Sulfonamide, die einen sauerstoffhaltigen heterozyklus enthalten als inhibitoren von aspartyl-protease |
Country Status (35)
Country | Link |
---|---|
US (2) | US5691372A (de) |
EP (3) | EP0833826B1 (de) |
JP (1) | JP4240532B2 (de) |
KR (1) | KR100485237B1 (de) |
CN (1) | CN1110491C (de) |
AP (2) | AP9600827A0 (de) |
AR (1) | AR004663A1 (de) |
AT (3) | ATE212344T1 (de) |
AU (1) | AU712913B2 (de) |
BG (1) | BG102041A (de) |
BR (1) | BR9608033A (de) |
CA (1) | CA2217745C (de) |
CO (1) | CO4700433A1 (de) |
CZ (1) | CZ329497A3 (de) |
DE (3) | DE69635679T2 (de) |
DK (1) | DK0833826T3 (de) |
EA (1) | EA000906B1 (de) |
EE (1) | EE9700254A (de) |
ES (3) | ES2256117T3 (de) |
GE (1) | GEP20001915B (de) |
HK (2) | HK1092791A1 (de) |
HU (1) | HUP9801948A3 (de) |
IL (1) | IL117962A0 (de) |
IS (1) | IS4575A (de) |
MY (1) | MY115797A (de) |
NO (1) | NO974744D0 (de) |
NZ (1) | NZ307342A (de) |
PE (1) | PE43697A1 (de) |
PL (1) | PL322904A1 (de) |
PT (1) | PT833826E (de) |
SK (1) | SK143097A3 (de) |
TR (1) | TR199701194T1 (de) |
TW (1) | TW404945B (de) |
WO (1) | WO1996033187A1 (de) |
ZA (1) | ZA962891B (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040122000A1 (en) | 1981-01-07 | 2004-06-24 | Vertex Pharmaceuticals Incorporated. | Inhibitors of aspartyl protease |
US7141609B2 (en) | 1992-08-25 | 2006-11-28 | G.D. Searle & Co. | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
EP0810209B1 (de) | 1992-08-25 | 2002-06-05 | G.D. Searle & Co. | Hydroxyethylaminosulfonamide verwendbar als Inhibitoren retroviraler Proteasen |
US5942253A (en) | 1995-10-12 | 1999-08-24 | Immunex Corporation | Prolonged release of GM-CSF |
US6121273A (en) | 1996-12-31 | 2000-09-19 | Gpi Nil Holdings, Inc | N-linked sulfonamides of heterocyclic thioesters |
US5874449A (en) * | 1996-12-31 | 1999-02-23 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of heterocyclic thioesters |
CA2289654A1 (en) * | 1997-05-17 | 1998-11-26 | Glaxo Group Limited | Antiviral combinations containing the carbocyclic nucleoside 1592u89 |
US5945441A (en) | 1997-06-04 | 1999-08-31 | Gpi Nil Holdings, Inc. | Pyrrolidine carboxylate hair revitalizing agents |
US6576231B2 (en) * | 1997-09-12 | 2003-06-10 | Schering Ag | Methods for treating HIV-Infected Patients by the Administration of GM-CSF and a protease inhibitor |
KR20010033595A (ko) * | 1997-12-24 | 2001-04-25 | 버텍스 파마슈티칼스 인코포레이티드 | 아스파틸 프로테아제 억제제의 전구약물 |
US6436989B1 (en) | 1997-12-24 | 2002-08-20 | Vertex Pharmaceuticals, Incorporated | Prodrugs of aspartyl protease inhibitors |
ATE285396T1 (de) * | 1998-06-19 | 2005-01-15 | Vertex Pharma | Sulfonamide als aspartyl-protease-inhibitoren |
WO1999067417A2 (en) * | 1998-06-23 | 1999-12-29 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Fitness assay and associated methods |
US6339101B1 (en) | 1998-08-14 | 2002-01-15 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
US6376517B1 (en) | 1998-08-14 | 2002-04-23 | Gpi Nil Holdings, Inc. | Pipecolic acid derivatives for vision and memory disorders |
US6218423B1 (en) | 1998-08-14 | 2001-04-17 | Gpi Nil Holdings, Inc. | Pyrrolidine derivatives for vision and memory disorders |
US6395758B1 (en) | 1998-08-14 | 2002-05-28 | Gpi Nil Holdings, Inc. | Small molecule carbamates or ureas for vision and memory disorders |
US6399648B1 (en) | 1998-08-14 | 2002-06-04 | Gpi Nil Holdings, Inc. | N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
US6337340B1 (en) | 1998-08-14 | 2002-01-08 | Gpi Nil Holdings, Inc. | Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
US6462072B1 (en) | 1998-09-21 | 2002-10-08 | Gpi Nil Holdings, Inc. | Cyclic ester or amide derivatives |
TNSN00027A1 (fr) | 1999-02-12 | 2005-11-10 | Vertex Pharma | Inhibiteurs de l'aspartyle protease |
DK1159278T3 (da) * | 1999-02-12 | 2006-04-10 | Vertex Pharma | Inhibitorer af aspartylprotease |
AR031520A1 (es) * | 1999-06-11 | 2003-09-24 | Vertex Pharma | Un compuesto inhibidor de aspartilo proteasa, una composicion que lo comprende y un metodo para tratar un paciente con dicha composicion |
AP1459A (en) * | 1999-10-06 | 2005-08-22 | Tibotec Pharm Ltd | Hexahydrofuro [2,3-b] furan-3- YL-N-{3-[(1,3- benzodioxol-5- ylsufonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor. |
CA2404687A1 (en) | 2000-03-30 | 2001-10-11 | Nemichand B. Jain | Sustained release beadlets containing stavudine |
NZ528954A (en) * | 2001-04-09 | 2005-04-29 | Tibotec Pharm Ltd | Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
EP1472536A4 (de) * | 2002-01-07 | 2007-02-14 | Sequoia Pharmaceuticals | Inhibitoren mit breitem spektrum |
US7157489B2 (en) * | 2002-03-12 | 2007-01-02 | The Board Of Trustees Of The University Of Illinois | HIV protease inhibitors |
WO2004033152A1 (en) * | 2002-10-11 | 2004-04-22 | Semplastics, L.L.C. | Retaining ring for use on a carrier of a polishing apparatus |
EP1565428A1 (de) * | 2002-11-27 | 2005-08-24 | Elan Pharmaceuticals, Inc. | Substituierte harnstoffe und carbamate |
US20050131042A1 (en) * | 2003-12-11 | 2005-06-16 | Flentge Charles A. | HIV protease inhibiting compounds |
US7763609B2 (en) * | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
WO2006104646A1 (en) * | 2005-03-11 | 2006-10-05 | Smithkline Beecham Corporation | Hiv protease inhibitors |
JP2007202679A (ja) * | 2006-01-31 | 2007-08-16 | Juki Corp | ミシンの糸調子装置 |
JP2007202833A (ja) * | 2006-02-02 | 2007-08-16 | Juki Corp | ミシンの糸調子装置 |
US9808527B2 (en) | 2006-11-21 | 2017-11-07 | Purdue Research Foundation | Methods and compositions for treating HIV infections |
WO2009091941A1 (en) | 2008-01-17 | 2009-07-23 | Purdue Research Foundation | Small molecule inhibitors of hiv proteases |
EP2307345A4 (de) | 2008-07-01 | 2012-05-02 | Purdue Research Foundation | Nichtpeptidinhibitoren der hiv-1-protease |
EP2304043A4 (de) | 2008-07-09 | 2012-05-30 | Purdue Research Foundation | Hiv-protease-hemmer und verfahren zu ihrer verwendung |
CN105272991B (zh) * | 2014-06-26 | 2017-11-07 | 成都中医药大学 | 一种化合物晶型 |
US11090030B2 (en) | 2016-11-10 | 2021-08-17 | Leltek Inc. | Ultrasound apparatus and ultrasound emission method |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3743722A (en) * | 1971-07-14 | 1973-07-03 | Abbott Lab | Anti-coagulant isolation |
FR2459235A1 (fr) * | 1979-06-14 | 1981-01-09 | Sanofi Sa | Nouveaux derives de sulfonyl-aniline, leur procede de preparation et leur application therapeutique |
JPS5946252A (ja) * | 1982-09-09 | 1984-03-15 | Dainippon Ink & Chem Inc | 含フツ素アミノカルボキシレ−トおよびその製法 |
JPS5948449A (ja) * | 1982-09-13 | 1984-03-19 | Dainippon Ink & Chem Inc | 直鎖状含フツ素アニオン化合物およびその製造方法 |
JPS6171830A (ja) * | 1984-09-17 | 1986-04-12 | Dainippon Ink & Chem Inc | 界面活性剤組成物 |
US4616088A (en) * | 1984-10-29 | 1986-10-07 | E. R. Squibb & Sons, Inc. | Amino acid ester and amide renin inhibitor |
US4629724A (en) * | 1984-12-03 | 1986-12-16 | E. R. Squibb & Sons, Inc. | Amino acid ester and amide renin inhibitors |
DE3635907A1 (de) * | 1986-10-22 | 1988-04-28 | Merck Patent Gmbh | Hydroxy-aminosaeurederivate |
CH676988A5 (de) * | 1987-01-21 | 1991-03-28 | Sandoz Ag | |
CA1340588C (en) * | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
IL91780A (en) * | 1988-10-04 | 1995-08-31 | Abbott Lab | History of the amine of the xenon-preventing xanine acid, the process for their preparation and the pharmaceutical preparations containing them |
WO1990007329A1 (en) * | 1989-01-06 | 1990-07-12 | The Regents Of The University Of California | Selection method for pharmacologically active compounds |
US5151438A (en) * | 1989-05-23 | 1992-09-29 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US5354866A (en) * | 1989-05-23 | 1994-10-11 | Abbott Laboratories | Retroviral protease inhibiting compounds |
IE902295A1 (en) * | 1989-07-07 | 1991-01-16 | Abbott Lab | Amino acid analog cck antagonists |
GB8927913D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
JPH07502970A (ja) * | 1990-06-01 | 1995-03-30 | ザ・デュポン・メルク・ファーマシュウティカル・カンパニー | 1,4―ジアミノ―2,3―ジヒドロキシブタン類 |
TW225540B (de) * | 1990-06-28 | 1994-06-21 | Shionogi & Co | |
ATE136888T1 (de) * | 1990-11-19 | 1996-05-15 | Monsanto Co | Retrovirale proteaseinhibitoren |
JPH06502866A (ja) * | 1990-11-19 | 1994-03-31 | モンサント カンパニー | レトロウィルスプロテアーゼ阻害物質 |
JPH06505963A (ja) * | 1990-11-19 | 1994-07-07 | モンサント カンパニー | レトロウイルスプロテアーゼ阻害剤 |
ES2059289T3 (es) * | 1990-11-19 | 1997-10-16 | Monsanto Co | Inhibidores de la proteasa retroviral. |
IE913840A1 (en) * | 1990-11-20 | 1992-05-20 | Abbott Lab | Retroviral protease inhibiting compounds |
CA2195027C (en) * | 1991-11-08 | 2000-01-11 | Joseph P. Vacca | Hiv protease inhibitors useful for the treatment of aids |
ES2091000T3 (es) * | 1992-05-20 | 1996-10-16 | Searle & Co | Metodo para elaborar intermedios utiles en la sintesis de inhibidores de proteasas retroviricas. |
EP0957093A3 (de) * | 1992-05-21 | 2000-04-12 | Monsanto Company | Retrovirusprotease Inhibitoren |
WO1994004491A1 (en) * | 1992-08-25 | 1994-03-03 | G.D. Searle & Co. | N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors |
EP0810209B1 (de) * | 1992-08-25 | 2002-06-05 | G.D. Searle & Co. | Hydroxyethylaminosulfonamide verwendbar als Inhibitoren retroviraler Proteasen |
JP4091654B2 (ja) * | 1992-08-25 | 2008-05-28 | ジー.ディー.サール、リミテッド、ライアビリティ、カンパニー | レトロウイルスプロテアーゼ阻害剤として有用なスルホニルアルカノイルアミノヒドロキシエチルアミノスルホンアミド |
US5723490A (en) * | 1992-09-08 | 1998-03-03 | Vertex Pharmaceuticals Incorporated | THF-containing sulfonamide inhibitors of aspartyl protease |
IS2334B (is) * | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
ATE183499T1 (de) * | 1992-10-30 | 1999-09-15 | Searle & Co | Sulfonylalkanoylaminohydroxyethylaminosulfamins uren verwendbar als inhibitoren retroviraler proteasen |
US6156768A (en) * | 1992-10-30 | 2000-12-05 | G. D. Searle & Co. | Alpha- and beta-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
WO1994018192A1 (en) * | 1993-02-12 | 1994-08-18 | Merck & Co., Inc. | Piperazine derivatives as hiv protease inhibitors |
TW281669B (de) * | 1993-02-17 | 1996-07-21 | Chugai Pharmaceutical Co Ltd | |
EP0715618B1 (de) * | 1993-08-24 | 1998-12-16 | G.D. Searle & Co. | Hydroxyaminosulfonamide verwendbar als inhibitoren retroviraler proteasen |
UA49803C2 (uk) * | 1994-06-03 | 2002-10-15 | Дж.Д. Сьорль Енд Ко | Спосіб лікування ретровірусних інфекцій |
-
1995
- 1995-04-19 US US08/424,810 patent/US5691372A/en not_active Expired - Lifetime
-
1996
- 1996-04-11 ZA ZA962891A patent/ZA962891B/xx unknown
- 1996-04-11 TW TW085104278A patent/TW404945B/zh not_active IP Right Cessation
- 1996-04-17 AR ARP960102210A patent/AR004663A1/es unknown
- 1996-04-17 AP APAP/P/1996/000827A patent/AP9600827A0/en unknown
- 1996-04-18 TR TR97/01194T patent/TR199701194T1/xx unknown
- 1996-04-18 CN CN96193903A patent/CN1110491C/zh not_active Expired - Fee Related
- 1996-04-18 WO PCT/US1996/005473 patent/WO1996033187A1/en active IP Right Grant
- 1996-04-18 AT AT96913811T patent/ATE212344T1/de active
- 1996-04-18 SK SK1430-97A patent/SK143097A3/sk unknown
- 1996-04-18 ES ES01113575T patent/ES2256117T3/es not_active Expired - Lifetime
- 1996-04-18 CZ CZ973294A patent/CZ329497A3/cs unknown
- 1996-04-18 DK DK96913811T patent/DK0833826T3/da active
- 1996-04-18 AT AT05028389T patent/ATE479674T1/de not_active IP Right Cessation
- 1996-04-18 MY MYPI96001465A patent/MY115797A/en unknown
- 1996-04-18 BR BR9608033A patent/BR9608033A/pt not_active Application Discontinuation
- 1996-04-18 KR KR1019970707346A patent/KR100485237B1/ko not_active IP Right Cessation
- 1996-04-18 DE DE69635679T patent/DE69635679T2/de not_active Expired - Lifetime
- 1996-04-18 EA EA199700330A patent/EA000906B1/ru not_active IP Right Cessation
- 1996-04-18 ES ES96913811T patent/ES2171670T3/es not_active Expired - Lifetime
- 1996-04-18 PL PL96322904A patent/PL322904A1/xx unknown
- 1996-04-18 AT AT01113575T patent/ATE314360T1/de active
- 1996-04-18 DE DE69618779T patent/DE69618779T2/de not_active Expired - Lifetime
- 1996-04-18 GE GEAP19963972A patent/GEP20001915B/en unknown
- 1996-04-18 EP EP96913811A patent/EP0833826B1/de not_active Expired - Lifetime
- 1996-04-18 AP APAP/P/1997/001104A patent/AP862A/en active
- 1996-04-18 PT PT96913811T patent/PT833826E/pt unknown
- 1996-04-18 HU HU9801948A patent/HUP9801948A3/hu unknown
- 1996-04-18 ES ES05028389T patent/ES2351970T3/es not_active Expired - Lifetime
- 1996-04-18 JP JP53195396A patent/JP4240532B2/ja not_active Expired - Lifetime
- 1996-04-18 CA CA2217745A patent/CA2217745C/en not_active Expired - Lifetime
- 1996-04-18 IL IL11796296A patent/IL117962A0/xx unknown
- 1996-04-18 PE PE1996000266A patent/PE43697A1/es not_active Application Discontinuation
- 1996-04-18 DE DE69638252T patent/DE69638252D1/de not_active Expired - Lifetime
- 1996-04-18 EP EP01113575A patent/EP1136479B1/de not_active Expired - Lifetime
- 1996-04-18 EE EE9700254A patent/EE9700254A/xx unknown
- 1996-04-18 EP EP05028389A patent/EP1637528B1/de not_active Expired - Lifetime
- 1996-04-18 AU AU56655/96A patent/AU712913B2/en not_active Expired
- 1996-04-19 CO CO96019067A patent/CO4700433A1/es unknown
-
1997
- 1997-10-02 IS IS4575A patent/IS4575A/is unknown
- 1997-10-08 NZ NZ307342A patent/NZ307342A/en unknown
- 1997-10-14 NO NO974744A patent/NO974744D0/no not_active Application Discontinuation
- 1997-11-13 BG BG102041A patent/BG102041A/xx unknown
- 1997-11-24 US US08/977,365 patent/US5990155A/en not_active Expired - Lifetime
-
1998
- 1998-09-22 HK HK06110563.0A patent/HK1092791A1/xx not_active IP Right Cessation
- 1998-09-22 HK HK98110833A patent/HK1009811A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE212344T1 (de) | Sulfonamide die einen sauerstoff-haltigen heterozyklus enthalten als inhibitoren von aspartyl-protease | |
NL300039I2 (nl) | Sulfonamideremmers van HIV-aspartylprotease. | |
NO974722D0 (no) | THF-inneholdende sulfonamidhemmere av aspartylprotease | |
ATE285396T1 (de) | Sulfonamide als aspartyl-protease-inhibitoren | |
NL300339I1 (nl) | Sulfonamidederivaten als progeneesmiddelen van aspartylproteaseremmers | |
DE69311810T2 (de) | N-(alkanoylamino-2-hydroxypropyl)-sulfonamide verwendbar als retrovirale proteaseninhibitoren | |
ATE71111T1 (de) | Peptid-derivate, renin- und saeureprotease hemmende mittel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |